Major Regulatory Reset Is Coming for Sunscreens
The Therapeutic Goods Administration (TGA) has launched a significant consultation that could reshape how sunscreens are tested, labelled, and regulated in Australia.
Running from 26 March to 23 May 2026, the consultation aims to strengthen confidence in sunscreen performance — a critical issue in a country with some of the highest skin cancer rates globally.
This isn’t a minor tweak. It’s a full framework review.
Why This Is Happening (And Why It Matters)
Let’s not sugar-coat it — the system has been under pressure.
Recent investigations revealed:
- Widespread SPF performance failures
- Inconsistent test results between laboratories
- Gaps in manufacturer understanding of regulatory obligations
In some cases, sunscreens marketed as SPF50+ performed dramatically lower — triggering recalls and regulatory scrutiny.
That’s a trust problem. And the TGA knows it.
Key Proposed Changes
The consultation outlines several reform areas that suppliers, importers, and retailers need to watch closely:
1. SPF Testing Overhaul
- Improved reliability and reproducibility of SPF testing
- Potential adoption of new testing technologies
- Increased scrutiny of testing methodologies
👉 Translation: “Test reports” alone won’t cut it anymore.
2. Laboratory Oversight
- Stronger regulation and accreditation of testing labs
- Increased transparency on how SPF claims are validated
👉 Expect tighter scrutiny of overseas labs — a known weak point.
3. Labelling Reform (The Big One)
Options being considered include:
- Keeping current SPF numbers
- Adding clearer explanatory information
- Replacing SPF numbers entirely with categories like:
- Low
- Medium
- High
- Very High
👉 This could fundamentally change how products are marketed and sold.
4. Lifecycle Quality Assurance
- Ongoing post-market testing expectations
- Stronger controls on ingredients and formulation consistency
👉 Compliance doesn’t stop at launch anymore.
5. Manufacturing & GMP Updates
- Review and likely update of Good Manufacturing Practice (GMP) guidance
- Addressing modern manufacturing risks
👉 Older processes = higher compliance risk.
6. Alignment Between Cosmetic & Therapeutic Sunscreens
- Clarification of regulatory boundaries
- Improved consistency in claims across categories
👉 Expect fewer loopholes.
What This Means for Industry
If these reforms land (and most will in some form), expect:
Higher Compliance Burden
- More robust evidence requirements
- Increased documentation and testing validation
Supply Chain Pressure
- Greater scrutiny on:
- Contract manufacturers
- Testing laboratories
- Ingredient sourcing
Marketing & Labelling Disruption
- Possible redesign of:
- Packaging
- Claims
- Online product listings
Regulatory Risk Exposure
- Weak compliance frameworks will be exposed quickly
- Expect more:
- ARTG cancellations
- Recalls
- Enforcement action
The Bigger Picture
This consultation signals something broader:
👉 The TGA is moving toward data-backed, lifecycle regulation
👉 Trust in SPF claims is now a regulatory priority
👉 “Set and forget” compliance is officially dead
What You Should Be Doing Now
If you supply, import, or sell sunscreens in Australia:
- Review your SPF substantiation (don’t assume it’s bulletproof)
- Audit your testing labs (especially offshore providers)
- Check labelling and claims alignment
- Stress-test your compliance framework against future requirements
Because once these reforms land — there won’t be much tolerance for getting it wrong.
Click on TGA Logo to read more
